Results 161 to 170 of about 2,979 (199)

Cariprazine: Chemistry, Pharmacodynamics, Pharmacokinetics, and Metabolism, Clinical Efficacy, Safety, and Tolerability

Expert Opinion on Drug Metabolism and Toxicology, 2013
INTRODUCTION: Cariprazine is an atypical antipsychotic in clinical development for the treatment of schizophrenia and bipolar mania/mixed episodes.
Leslie Citrome
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cariprazine

Nervenheilkunde, 2020
Abstract Objective Cariprazine is a new antipsychotic drug approved for the treatment of schizophrenia in Europe in 2017. Clinical studies suggest advantages of cariprazine in comparison to other antipsychotic agents regarding therapeutic effects on “negative symptoms”, antipsychotic-induced weight gain and increased serum prolactin levels ...
Maximilian Gahr, Simon Riedesser
openaire   +1 more source

Cariprazine (Vraylar)

Canadian Journal of Health Technologies
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the ...
openaire   +1 more source

Cariprazine

Reactions Weekly, 2021
openaire   +1 more source

Cariprazine

Reactions Weekly, 2019
openaire   +2 more sources

Cariprazine

Reactions Weekly
  +4 more sources

Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

American Journal of Psychiatry, 2023
Maurizio Fava, Paul P Yeung, Ludmyla Rekeda   +2 more
exaly  

Cariprazine/olanzapine

Reactions Weekly, 2022
openaire   +1 more source